HLA-B and HIV infectious disease: Accordingly, the Brazilian Ministry of Health requires testing for HLA‐B*57:01 prior to inclusion of abacavir in antiretroviral combined therapy for HIV infection; the test is available free of charge to users of the Brazilian SUS.